CLINICAL_TRIALS
trial_result
· 2018-11-21
Clinical Trial Update: Shenfu Injection Improves Arterial Vascular Reactivity [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates suggest Shenfu Injection may improve arterial vascular reactivity in septic shock.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jianfeng Xie | Conditions: Septic Shock, Shenfu | Phase 2, Phase 3 | Status: UNKNOWN